WB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis : A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT) | Acta dermato-venereologica | 2025 | 10 | 26 | |||
| Approved systemic drugs needed for dermatosis like alopecia areata, hidradenitis and vitiligo : A SPIN-FRT evaluation | JEADV. Journal of the European Academy of Dermatology and Venereology | 2025 | 4 | 0 | |||
| Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors : 2024 update | Annals of the rheumatic diseases | 2025 | 2 | 100 | |||
| Bimekizumab Efficacy in Psoriasis by Subgroups : Post Hoc Analysis of Phase 3/3b Clinical Trials | Dermatology and therapy | 2025 | 3 | 50 | |||
| Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression : Recommendations from a SPIN-FRT expert consensus | JEADV. Journal of the European Academy of Dermatology and Venereology | 2025 | 62 | 0 | |||
| Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year | Dermatology and therapy | 2025 | 5 | 6 | |||
| The ‘Mono-Side’ of Cutaneous Adverse Drug Reactions | JEADV. Journal of the European Academy of Dermatology and Venereology | 2025 | 15 | 0 | |||
| Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics : post hoc analysis of a phase 3 study | Clinical rheumatology | 2024 | 92 | 61 | |||
| Advances in Psoriatic Disease Research : Insights From GRAPPA Pilot Research Awardees | Journal of rheumatology | 2024 | 39 | 0 | |||
| Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections : Data from the German Psoriasis Registry PsoBest | Journal of clinical medicine | 2024 | 39 | 98 | |||
| Efficacy and safety of pharmacological treatment of psoriatic arthritis : a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis | Annals of the rheumatic diseases | 2024 | 53 | 184 | |||
| Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry Study | Journal of psoriasis and psoriatic arthritis | 2024 | 32 | 98 | |||
| EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies : 2023 update | Annals of the rheumatic diseases | 2024 | 61 | 428 | |||
| Psoriasis localization patterns in the Swiss Psoriasis Registry (SDNTT) over 11 years : an analysis by sex and age | Archives of dermatological research | 2024 | 35 | 50 | |||
| Impact dermatologique du changement climatique | Revue médicale suisse | 2024 | 55 | 23 | |||
| Sex differences in adverse events from systemic treatments for psoriasis : A decade of insights from the Swiss Psoriasis Registry (SDNTT) | Journal of the European Academy of Dermatology and Venereology | 2023 | 76 | 0 | |||
| Statins and psoriasis : Position statement by the Psoriasis Task Force of the European Academy of Dermatology and Venerology | JEADV. Journal of the European Academy of Dermatology and Venereology | 2023 | 91 | 0 | |||
| EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis | Annals of the rheumatic diseases | 2023 | 131 | 156 | |||
| Revisiting the interleukin 17 family of cytokines in psoriasis : pathogenesis and potential targets for innovative therapies | Frontiers in immunology | 2023 | 71 | 252 | |||
| Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience : Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study | ACR open rheumatology | 2023 | 111 | 148 | |||
| Adipose-derived stromal cells within a gelatin matrix acquire enhanced regenerative and angiogenic properties: a pre-clinical study for application to chronic wounds | Biomedicines | 2023 | 161 | 84 | |||
| Inflammation modulates intercellular adhesion and mechanotransduction in human epidermis via ROCK2 | iScience | 2023 | 99 | 203 | |||
| Full-body blue light irradiation as treatment for atopic dermatitis : a randomized sham-controlled clinical trial (AD-Blue) | Journal der Deutschen Dermatologischen Gesellschaft | 2023 | 70 | 173 | |||
| Parlons du prurit | Revue médicale suisse | 2023 | 140 | 54 | |||
| Paradoxical nail psoriasis induced by the IL-17A inhibitor ixekizumab in palmoplantar pustulosis | International journal of dermatology | 2023 | 66 | 0 | |||
| Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment : Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis | Journal of rheumatology | 2023 | 89 | 79 | |||
| Elevating the Standard of Care for Patients with Psoriasis : 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative | Dermatology and therapy | 2023 | 110 | 45 | |||
| Mechanotransduction in Skin Inflammation | Cells | 2022 | 194 | 550 | |||
| IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis | Rheumatology | 2022 | 322 | 5 | |||
| La dermatologie à l’ère du Covid-19 | Revue médicale suisse | 2022 | 386 | 79 | |||
| Pathogenesis-oriented therapy of psoriasis using biologics | Expert opinion on biological therapy | 2022 | 170 | 0 | |||
| IL ‐38 orchestrates proliferation and differentiation in human keratinocytes | Experimental dermatology | 2022 | 268 | 193 | |||
| Comparative Effectiveness of Guselkumab in Psoriatic Arthritis: Updates to a Systematic Literature Review and Network Meta-Analysis | Rheumatology | 2022 | 164 | 548 | |||
| Adipose-Derived Stromal Cells for Chronic Wounds: Scientific Evidence and Roadmap Toward Clinical Practice | Stem cells translational medicine | 2022 | 179 | 229 | |||
| Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies | RMD open | 2022 | 255 | 126 | |||
| Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis | The Journal of rheumatology | 2021 | 318 | 403 | |||
| Interleukin-17E, inducible nitric oxide synthase and arginase1 as new biomarkers in the identification of neutrophilic dermatoses | Clinical and experimental dermatology | 2021 | 169 | 89 | |||
| Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität | Journal der Deutschen Dermatologischen Gesellschaft | 2021 | 259 | 970 | |||
| Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis | Rheumatology | 2021 | 238 | 501 | |||
| Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis. Results from tissue-engineered scleroderma epidermis | Arthritis and Rheumatology | 2021 | 411 | 538 | |||
| German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendations | Journal der Deutschen Dermatologischen Gesellschaft | 2021 | 300 | 146 | |||
| German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: Treatment monitoring and specific clinical or comorbid situations | Journal der Deutschen Dermatologischen Gesellschaft | 2021 | 301 | 391 | |||
| LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from Japan | PloS one | 2021 | 94 | 103 | |||
| Un équilibre à fleur de peau | Revue médicale suisse | 2021 | 252 | 160 | |||
| Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm – Teil 1: Therapieziele und Therapieempfehlungen | Journal der Deutschen Dermatologischen Gesellschaft | 2021 | 428 | 331 | |||
| Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced | RMD open | 2021 | 236 | 127 | |||
| Psoriasisarthritis: Relevantes für die dermatologische Praxis | Der Hautarzt | 2021 | 169 | 0 | |||
| Psoriasis : pourquoi en parler encore et toujours ? | Revue médicale suisse | 2021 | 252 | 233 | |||
| Guselkumab: the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis in Adults | Expert review of clinical immunology | 2021 | 140 | 0 | |||
| Psoriasisarthritis : Wichtige Aspekte für die Praxis | Der Hautarzt | 2021 | 127 | 1 | |||
| IL-25 (IL-17E) in epithelial immunology and pathophysiology | The journal of allergy and clinical immunology | 2021 | 192 | 0 | |||
| Voneinander lernen, miteinander behandeln | Der Hautarzt | 2021 | 151 | 97 | |||
| Dermatologie: Passage de la dermatite atopique au psoriasis - et retour | Revue médicale suisse | 2021 | 255 | 359 | |||
| Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial | Lancet. Oncology | 2021 | 247 | 0 | |||
| Circadian clocks guide dendritic cells into skin lymphatics | Nature immunology | 2021 | 467 | 181 | |||
| Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study | British journal of dermatology | 2021 | 178 | 0 | |||
| Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases | 2021 | 341 | 295 | |||
| Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey | Rheumatology and Therapy | 2020 | 207 | 114 | |||
| IL-17A in psoriasis and beyond: cardiovascular and metabolic implications | Frontiers in Immunology | 2020 | 301 | 235 | |||
| Targeted cutaneous delivery of etanercept using Er:YAG fractional laser ablation | International Journal of Pharmaceutics | 2020 | 329 | 0 | |||
| Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care | PLOS ONE | 2020 | 231 | 131 | |||
| Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health-related quality of life from two randomized phase 3 studies | Journal of the European Academy of Dermatology and Venereology | 2020 | 217 | 239 | |||
| Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase ii study | RMD Open | 2020 | 186 | 94 | |||
| IL-17E (IL-25) and IL-17A differentially affect the functions of human keratinocytes | The Journal of Investigative Dermatology | 2020 | 490 | 259 | |||
| The Janus Kinase inhibitor tofacitinib impacts human dendritic cell differentiation and favours M1 macrophage development | Experimental Dermatology | 2020 | 376 | 0 | |||
| Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study | Journal of the European Academy of Dermatology and Venereology | 2020 | 198 | 1 | |||
| Zytokine der IL-17-Familie bei der Psoriasis | Journal der Deutschen Dermatologischen Gesellschaft | 2020 | 181 | 60 | |||
| Les cytokines IL-17, une famille en expansion utilisée comme cible pour des thérapies anti-inflammatoires innovantes | Revue médicale suisse | 2020 | 231 | 178 | |||
| Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure | Dermatology and Therapy | 2020 | 372 | 294 | |||
| Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research | RMD Open | 2020 | 175 | 157 | |||
| Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial | Lancet | 2020 | 201 | 155 | |||
| Cytokines of the IL-17 family in psoriasis | Journal der Deutschen Dermatologischen Gesellschaft | 2020 | 207 | 187 | |||
| GRAPPA Trainees Symposium 2019: A Report from the GRAPPA 2019 Annual Meeting | Journal of rheumatology. Supplement | 2020 | 194 | 0 | |||
| EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update | Annals of the Rheumatic Diseases | 2020 | 437 | 242 | |||
| Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care | European journal of dermatology | 2020 | 223 | 0 | |||
| Traitement des kératoses actiniques : l'embarras du choix | Revue médicale suisse | 2020 | 332 | 1 | |||
| Cave linguam – ce qu'on dit (ou écrit) et ce que le public entend… | Revue médicale suisse | 2019 | 245 | 90 | |||
| Best-practice Indicators in Psoriatic Disease Care | Journal of Rheumatology. Supplement | 2019 | 232 | 0 | |||
| Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse line | Nature Communications | 2019 | 354 | 357 | |||
| Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies | Journal of Allergy and Clinical Immunology | 2019 | 274 | 0 | |||
| Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice | Journal of the European Academy of Dermatology and Venereology | 2019 | 360 | 0 | |||
| Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis | Journal of Rheumatology. Supplement | 2019 | 305 | 0 | |||
| Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial | Arthritis Care and Research | 2019 | 307 | 155 | |||
| Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients | British Journal of Dermatology | 2019 | 334 | 0 | |||
| Linkage between patients' characteristics and prescribed systemic treatments for psoriasis: a semantic connectivity map analysis of the Swiss Dermatology Network for Targeted Therapies registry | Journal of the European Academy of Dermatology and Venereology | 2019 | 303 | 0 | |||
| Treatment of Atopic Dermatitis Using a Full-Body Blue Light Device (AD-Blue): Protocol of a Randomized Controlled Trial | JMIR Research Protocols | 2019 | 250 | 335 | |||
| Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes | PLOS ONE | 2019 | 381 | 211 | |||
| GRAPPA Trainees Symposium 2018: A Report from the GRAPPA 2018 Annual Meeting | Journal of Rheumatology. Supplement | 2019 | 257 | 0 | |||
| Autoreactive T-Lymphocytes in Inflammatory Skin Diseases | Frontiers in Immunology | 2019 | 337 | 228 | |||
| Un cas de « peau d'orange » sans cancer | Revue médicale suisse | 2019 | 1,065 | 54 | |||
| IL-17E (IL-25) Enhances Innate Immune Responses during Skin Inflammation | Journal of Investigative Dermatology | 2019 | 342 | 0 | |||
| Innovation en dermatologie : il est temps de changer de mentalité ! | Revue médicale suisse | 2018 | 265 | 89 | |||
| Patient perceptions of clear/almost clear skin in moderate-to-severe plaque psoriasis: results of the Clear About Psoriasis worldwide survey | Journal of the European Academy of Dermatology and Venereology | 2018 | 396 | 143 | |||
| Recognition of early melanoma: a monocentric dermoscopy follow-up study comparing de novo melanoma with nevus-associated melanoma | International Journal of Dermatology | 2018 | 370 | 0 | |||
| Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences | Frontiers in Immunology | 2018 | 343 | 254 | |||
| Who will treat inflammatory skin diseases in the year 2020? | Journal of the European Academy of Dermatology and Venereology | 2018 | 284 | 0 | |||
| GRAPPA Trainees Symposium 2017: A Report from the GRAPPA 2017 Annual Meeting | The Journal of rheumatology. Supplement | 2018 | 295 | 0 | |||
| The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond | Frontiers in Immunology | 2018 | 392 | 391 | |||
| Roger federer pourrait-il jouer en portant un large sombrero ? | Revue médicale suisse | 2018 | 331 | 5 | |||
| Bêtabloquants : un nouveau traitement dermatologique ? | Revue médicale suisse | 2018 | 439 | 705 | |||
| Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus | Journal of the European Academy of Dermatology and Venereology | 2018 | 432 | 0 | |||
| Fumarates – bien plus qu'un additif alimentaire | Revue médicale suisse | 2018 | 344 | 177 | |||
| S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 1 - Systemische Therapie | Journal der Deutschen Dermatologischen Gesellschaft | 2018 | 323 | 1 | |||
| Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study | The Lancet | 2018 | 332 | 0 | |||
| Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins | Clinical and Experimental Allergy | 2018 | 342 | 0 | |||
| Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional Study | Rheumatology and Therapy | 2018 | 355 | 166 | |||
| S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 2 - Besondere Patientengruppen und spezielle Behandlungssituationen | Journal der Deutschen Dermatologischen Gesellschaft | 2018 | 321 | 2 | |||
| The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis | Journal of the European Academy of Dermatology and Venereology | 2017 | 508 | 1,159 | |||
| IL-17A localizes in the exocytic compartment of mast cells in psoriatic skin | British Journal of Dermatology | 2017 | 408 | 2 | |||
| Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment | Clinical Reviews in Allergy and Immunology | 2017 | 451 | 0 | |||
| Altérations unguéales : à quoi penser dans la pratique courante en médecine générale ? | Revue médicale suisse | 2017 | 541 | 1,273 | |||
| Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting | Journal of Rheumatology | 2017 | 396 | 0 | |||
| Overexpression of the human antigen R suppresses the immediate paradoxical proliferation of melanoma cell subpopulations in response to suboptimal BRAF inhibition | Cancer Medicine | 2017 | 492 | 171 | |||
| New biologics in psoriasis - progress and problems | Journal of the European Academy of Dermatology and Venereology | 2017 | 367 | 1 | |||
| Choisir le bon médicament pour votre patient : evidence vs eminence-based medicine | Revue médicale suisse | 2017 | 374 | 137 | |||
| "Evergreen" Psoriasis - Neues zu Genetik, Therapie, und überhaupt | Journal der Deutschen Dermatologischen Gesellschaft | 2017 | 410 | 2 | |||
| Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation | PLOS ONE | 2017 | 471 | 301 | |||
| Dermal adipocytes' claim for fame in psoriasis | Experimental Dermatology | 2017 | 580 | 3 | |||
| Les indications dermatologiques du laser : au-delà de la cosmétique | Revue médicale suisse | 2017 | 464 | 538 | |||
| In vivo reflectance confocal microscopy: a useful non-invasive tool to assess the response to isolated limb perfusion for superficial pigmented melanoma in-transit metastatic disease. Report of a case | Dermatology Parctical and Conceptual | 2017 | 393 | 0 | |||
| Keratinocyte-derived IL-17E contributes to inflammation in psoriasis | Journal of investigative dermatology | 2016 | 663 | 13 | |||
| IL-22 capacitates dermal fibroblast responses to TNF in scleroderma | Annals of the rheumatic diseases | 2016 | 706 | 7 | |||
| Komorbidität bei Psoriasis vulgaris | Der Hautarzt | 2016 | 486 | 1 | |||
| Superiority in Quality of Life Improvement of Biologics over Conventional Systemic Drugs in a Swiss Real-Life Psoriasis Registry | Dermatology | 2016 | 547 | 0 | |||
| Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT | Dermatology | 2016 | 500 | 2 | |||
| Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris | Dermatology | 2016 | 470 | 0 | |||
| Surinfection de plaie chronique par Pseudomonas aeruginosa | Revue médicale suisse | 2015 | 581 | 2 | |||
| Psoriasis | Lancet | 2015 | 578 | 8 | |||
| The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists | Dermatology | 2015 | 462 | 0 | |||
| Qualifying unmet needs and improving standards of care in psoriatic arthritis | Arthritis care and research | 2014 | 565 | 0 | |||
| Epidermal insulin resistance as a therapeutic target in acanthosis nigricans? | Acta dermato-venereologica | 2014 | 535 | 2 | |||
| GRAPPA 2013 basic/translational/clinical science update: comorbidity monitoring | Journal of rheumatology | 2014 | 546 | 0 | |||
| Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review | Journal of rheumatology | 2014 | 457 | 0 | |||
| 'Upgrading' psoriasis responsibly | Experimental dermatology | 2014 | 561 | 0 | |||
| More than skin-deep: the many dimensions of the psoriatic disease | Schweizerische medizinische Wochenschrift | 2014 | 544 | 0 | |||
| The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting | Journal of rheumatology | 2014 | 489 | 0 | |||
| Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) | Journal of rheumatology | 2014 | 592 | 1 | |||
| Reversal of Murine Epidermal Atrophy by Topical Modulation of Calcium Signaling | Journal of investigative dermatology | 2014 | 580 | 151 | |||
| GRAPPA Fellows Symposium Adjacent to the European Academy of Dermatology and Venereology (EADV) Congress, Istanbul, 2013: a meeting report | Journal of rheumatology | 2014 | 568 | 0 | |||
| German psoriasis registry PsoBest: objectives, methodology and baseline data | Journal der Deutschen Dermatologischen Gesellschaft | 2014 | 511 | 0 | |||
| Héparines et réactions cutanées : du diagnostic à la prise en charge | Revue médicale suisse | 2013 | 568 | 1 | |||
| Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin | British journal of dermatology | 2013 | 640 | 1 | |||
| Erythème scarlatiniforme desquamatif récidivant ou maladie de Féréol-Besnier: une entité peu connue | Revue médicale suisse | 2013 | 978 | 1 | |||
| Burden of Disease: Psoriasis and Psoriatic Arthritis | American journal of clinical dermatology | 2013 | 686 | 1 | |||
| De la compétition à la concertation | Revue médicale suisse | 2013 | 533 | 2 | |||
| High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy | Journal of allergy and clinical immunology | 2013 | 626 | 1 | |||
| Methylprednisolone Blocks Autoantibody-Induced Tissue Damage in Experimental Models of Bullous Pemphigoid and Epidermolysis Bullosa Acquisita through Inhibition of Neutrophil Activation | Journal of investigative dermatology | 2013 | 599 | 1 | |||
| Heparin-induced skin lesions | Lancet | 2012 | 616 | 1 | |||
| Neue Erkenntnisse zu Fumarsaureestern (Fumaderm(R)): Ergebnisse des 2. Experten-Workshops | Journal der Deutschen Dermatologischen Gesellschaft | 2012 | 530 | 0 | |||
| Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experience | Thrombosis research | 2012 | 630 | 0 | |||
| The psoriasis xenograft SCID mouse model : a tool in translational research | British journal of dermatology | 2012 | 661 | 1 | |||
| Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meeting | Journal of rheumatology | 2012 | 649 | 0 | |||
| Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis | Journal of investigative dermatology | 2012 | 601 | 0 | |||
| Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives | Current rheumatology reports | 2012 | 616 | 0 | |||
| Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the beta-sheet structure of MIF | The Journal of biological chemistry | 2012 | 619 | 0 | |||
| German S3-guidelines on the treatment of psoriasis vulgaris (short version) | Archives of dermatological research | 2012 | 714 | 0 | |||
| Jenseits der Immunpathogenese Insulinresistenz und „epidermale Dysfunktion“ / Beyond immunopathogenesis. Insulin resistance and "epidermal dysfunction" | Der Hautarzt | 2012 | 621 | 0 | |||
| Moderne Psoriasistherapie: Evidenzbasiert, patientengerecht, zielorientiert / Modern therapy of psoriasis : evidence-based, patient-centered, goal-oriented | Der Hautarzt | 2012 | 585 | 364 | |||
| Psoriasis | Der Hautarzt | 2012 | 650 | 4 | |||
| S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update | Journal der Deutschen Dermatologischen Gesellschaft | 2012 | 721 | 0 | |||
| Perspective: Don't be superficial | Nature | 2012 | 560 | 320 | |||
| Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation | PloS one | 2011 | 659 | 363 | |||
| Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting | Journal of rheumatology | 2011 | 619 | 0 | |||
| Systemic antipsoriatic therapy may reverse endothelial dysfunction | British journal of dermatology | 2011 | 568 | 0 | |||
| S3-Leitlinie zur Therapie der Psoriasis vulgaris Update 2011 | Journal der Deutschen Dermatologischen Gesellschaft | 2011 | 561 | 0 | |||
| The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review | Contact dermatitis | 2011 | 622 | 0 | |||
| PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells | PloS one | 2011 | 667 | 408 | |||
| Changes in the sex hormone profile of male patients with moderate-to-severe plaque-type psoriasis under systemic therapy: results of a prospective longitudinal pilot study | Archives of dermatological research | 2011 | 679 | 0 | |||
| Endogenous mu-opioid peptides modulate immune response towards malignant melanoma | Experimental dermatology | 2011 | 550 | 1 | |||
| Neue Erkenntnisse zu Fumarsaureestern (Fumaderm((R))): Ergebnisse eines Experten-Workshops | Journal der Deutschen Dermatologischen Gesellschaft | 2011 | 681 | 0 | |||
| Microdialysis documents changes in the micromilieu of psoriatic plaques under continuous systemic therapy | Experimental dermatology | 2011 | 607 | 0 | |||
| Clinical long-term studies: data collection and assessment | Journal der Deutschen Dermatologischen Gesellschaft | 2011 | 589 | 0 | |||
| A 41 year old man with an itchy rash | BMJ. British medical journal | 2011 | 578 | 0 | |||
| Therapy of psoriasis in childhood and adolescence - a German expert consensus | Journal der Deutschen Dermatologischen Gesellschaft | 2011 | 648 | 0 | |||
| Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study | JEADV. Journal of the European Academy of Dermatology and Venereology | 2011 | 542 | 0 | |||
| Summary of minutes of the GRAPPA meeting adjacent to the American Academy of Dermatology 67th Annual Meeting | Journal of rheumatology | 2011 | 537 | 0 | |||
| Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial | Archives of dermatological research | 2011 | 656 | 0 | |||
| The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity | Experimental dermatology | 2011 | 643 | 0 | |||
| Low allergenic potential with fondaparinux: results of a prospective investigation | Mayo Clinic proceedings | 2010 | 563 | 0 | |||
| Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis | Experimental dermatology | 2010 | 695 | 0 | |||
| Evidence-based (S3) guideline for the treatment of psoriasis vulgaris - Update: "Therapeutic options" and "Efalizumab" | Journal der Deutschen Dermatologischen Gesellschaft | 2010 | 624 | 0 | |||
| Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis | Experimental dermatology | 2010 | 596 | 0 | |||
| EADV preceptorship: advances in dermatology | JEADV. Journal of the European Academy of Dermatology and Venereology | 2010 | 637 | 0 | |||
| ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma | Biochemical and biophysical research communications | 2010 | 641 | 0 | |||
| Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia | Journal of thrombosis and haemostasis | 2010 | 643 | 0 | |||
| Platelet, not endothelial, P-selectin expression contributes to generation of immunity in cutaneous contact hypersensitivity | The American journal of pathology | 2010 | 590 | 0 | |||
| Juvenile psoriasis and its clinical management: a European expert group consensus | Journal der Deutschen Dermatologischen Gesellschaft | 2010 | 575 | 0 | |||
| Managing comorbid disease in patients with psoriasis | BMJ. British medical journal | 2010 | 623 | 0 | |||
| Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E- and P-selectin, VCAM-1 and PECAM-1 | Experimental dermatology | 2010 | 626 | 0 | |||
| Constitutive and functionally relevant expression of JAM-C on platelets | Thrombosis and haemostasis | 2010 | 584 | 0 | |||
| Therapieempfehlungen fur Psoriasisarthritis | Zeitschrift für Rheumatologie | 2009 | 588 | 0 | |||
| PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions | Journal of investigative dermatology | 2009 | 502 | 0 | |||
| Managing comorbidities in psoriasis | Actas dermo-sifiliográficas | 2009 | 589 | 0 | |||
| Psoriasis--a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives | Journal der Deutschen Dermatologischen Gesellschaft | 2009 | 553 | 0 | |||
| Treatment recommendations for psoriatic arthritis | Annals of the rheumatic diseases | 2009 | 547 | 1 | |||
| Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with alpha4beta1 integrin | Immunology | 2009 | 648 | 0 | |||
| Incidence and causes of heparin-induced skin lesions | CMAJ. Canadian Medical Association journal | 2009 | 585 | 0 | |||
| Ausdauer-Leistungsfahigkeit von Triathlon-Athleten mit Typ-1-Diabetes | Deutsche Medizinische Wochenschrift | 2009 | 633 | 0 | |||
| Komorbiditaten bei Psoriasis vulgaris | Der Hautarzt | 2009 | 683 | 0 | |||
| Computer-aided analysis of cell interactions under dynamic flow conditions | Experimental dermatology | 2009 | 519 | 0 | |||
| Research in practice: the systemic aspects of psoriasis | Journal der Deutschen Dermatologischen Gesellschaft | 2008 | 528 | 0 | |||
| Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion molecule expression | Journal of investigative dermatology | 2008 | 617 | 0 | |||
| Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin | JEADV. Journal of the European Academy of Dermatology and Venereology | 2008 | 609 | 0 | |||
| The influence of heparin's molecular weight and the incidence of delayed type hypersensitivity reactions revisited; in response to Grims et al., Br J Dermatol 2007; 157:514-17 | British journal of dermatology | 2008 | 584 | 0 | |||
| Initiative for quality in psoriasis and psoriatic arthritis | Journal of rheumatology | 2008 | 526 | 0 | |||
| Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences | Giornale italiano di dermatologia e venereologia | 2008 | 464 | 0 | |||
| Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation | The Journal of biological chemistry | 2008 | 618 | 0 | |||
| Psoriasis: a possible risk factor for development of coronary artery calcification | British journal of dermatology | 2007 | 558 | 0 | |||
| P-selectin: a common therapeutic target for cardiovascular disorders, inflammation and tumour metastasis | Expert opinion on therapeutic targets | 2007 | 652 | 0 | |||
| Psoriasis and risk of myocardial infarction | JAMA | 2007 | 545 | 0 | |||
| Psoriasis patients show signs of insulin resistance | British journal of dermatology | 2007 | 587 | 0 | |||
| Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions | Haematologica | 2007 | 584 | 0 | |||
| Quality indicators in psoriatic arthritis | Clinical and Experimental Rheumatology | 2007 | 476 | 0 | |||
| Assessment of publications using methods of evidence-based medicine: an introduction using a dermatological clinical study | Journal der Deutschen Dermatologischen Gesellschaft | 2007 | 558 | 0 | |||
| Diminished lymphocyte adhesion and alleviation of allergic responses by small-molecule- or antibody-mediated inhibition of L-selectin functions | Journal of investigative dermatology | 2007 | 529 | 0 | |||
| Cost-effectiveness of psoriasis therapy with etanercept in Germany | Journal der Deutschen Dermatologischen Gesellschaft | 2007 | 579 | 0 | |||
| Kutane Botryomykose. Eine selten diagnostizierte bakterielle Infektion der Haut | Der Hautarzt | 2007 | 613 | 0 | |||
| Efalizumab in the treatment of psoriasis | Biologics | 2007 | 509 | 0 | |||
| German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version) | Archives of dermatological research | 2007 | 751 | 0 | |||
| Animal models of psoriasis | Clinics in dermatology | 2007 | 527 | 0 | |||
| Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris | Journal der Deutschen Dermatologischen Gesellschaft | 2007 | 615 | 0 | |||
| Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature | Archives of dermatological research | 2007 | 632 | 0 | |||
| Psoriasis-SCID-Maus-Modell | Der Hautarzt | 2006 | 630 | 1 | |||
| Therapie der Psoriasis vulgaris mit Efalizumab | Journal der Deutschen Dermatologischen Gesellschaft | 2006 | 561 | 0 | |||
| Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo | Experimental dermatology | 2006 | 637 | 0 | |||
| The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity | Biochemical pharmacology | 2006 | 540 | 0 | |||
| Papeln am rechten Unterschenkel eines afrikanischen Madchens | Journal der Deutschen Dermatologischen Gesellschaft | 2006 | 565 | 0 | |||
| Management of cutaneous type IV hypersensitivity reactions induced by heparin | Thrombosis and haemostasis | 2006 | 539 | 0 | |||
| Structure-function relation of efomycines, a family of small-molecule inhibitors of selectin functions | Journal of investigative dermatology | 2006 | 602 | 0 | |||
| Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities | Mini-reviews in medical chemistry | 2006 | 528 | 0 | |||
| Interactive large-group teaching in a dermatology course | Medical teacher | 2006 | 603 | 0 | |||
| Biologic therapies for psoriasis. A systematic review | Journal of rheumatology | 2006 | 556 | 0 | |||
| The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo | Thrombosis and haemostasis | 2006 | 585 | 0 | |||
| Leukocyte adhesion: a suitable target for anti-inflammatory drugs | Current pharmaceutical design | 2006 | 498 | 0 | |||
| Chronic venous insufficiency - a potential trigger for localized scleroderma | JEADV. Journal of the European Academy of Dermatology and Venereology | 2006 | 616 | 0 | |||
| Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus | JEADV. Journal of the European Academy of Dermatology and Venereology | 2006 | 613 | 0 | |||
| S3-Leitlinie zur Therapie der Psoriasis vulgaris | Journal der Deutschen Dermatologischen Gesellschaft | 2006 | 615 | 0 | |||
| Therapie der Psoriasis-Arthritis und der Psoriasis vulgaris mit Infliximab | Journal der Deutschen Dermatologischen Gesellschaft | 2006 | 556 | 0 | |||
| Psoriasis | The New England journal of medicine | 2005 | 495 | 1 | |||
| Leukocyte extravasation as a target for anti-inflammatory therapy - Which molecule to choose? | Experimental dermatology | 2005 | 573 | 0 | |||
| Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases | British journal of dermatology | 2005 | 552 | 0 | |||
| Therapie der Psoriasis vulgaris und Psoriasis--Arthritis mit Etanercept | Journal der Deutschen Dermatologischen Gesellschaft | 2005 | 588 | 1 | |||
| Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma | Journal der Deutschen Dermatologischen Gesellschaft | 2005 | 564 | 0 | |||
| Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation | Journal of investigative dermatology | 2005 | 647 | 0 | |||
| Eyelid dermatitis caused by an eyelash former | Contact dermatitis | 2005 | 567 | 0 | |||
| Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model | British journal of dermatology | 2005 | 503 | 0 | |||
| Safety and efficacy of alefacept in elderly patients and other special populations | Journal of drugs in dermatology | 2005 | 510 | 0 | |||
| Experimental approaches to lymphocyte migration in dermatology in vitro and in vivo | Experimental dermatology | 2005 | 556 | 0 | |||
| Psoriasis: Clinical manifestations, pathogenesis and therapeutic perspectives | Discovery medicine | 2005 | 498 | 0 | |||
| The psoriasis SCID mouse model: a tool for drug discovery? | Ernst Schering Research Foundation workshop | 2005 | 471 | 0 | |||
| Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides | Thrombosis and haemostasis | 2005 | 602 | 1 | |||
| Complicated mycosis fungoides mimicking facial erysipelas | British journal of dermatology | 2005 | 544 | 0 | |||
| Toleranz von Coxiben bei Intoleranz gegenuber nicht-steroidalen Antirheumatika (NSAR) | Deutsche Medizinische Wochenschrift | 2005 | 642 | 0 | |||
| Fixed drug eruption caused by articain | Allergy | 2004 | 476 | 0 | |||
| Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules | Journal of investigative dermatology | 2004 | 589 | 0 | |||
| The alpha-defensins HNP-1 and HNP-2 are dominant self-peptides presented by HLA class-II molecules in lesional psoriatic skin | EJD. European journal of dermatology | 2004 | 499 | 1 | |||
| Biological therapies in the systemic management of psoriasis: International Consensus Conference | British journal of dermatology | 2004 | 590 | 0 | |||
| Neue Therapieoption fur Problempatienten. Was bringen "Biologics" bei Psoriasis? | MMW, Fortschritte der Medizin | 2004 | 473 | 0 | |||
| Targeting selectin functions in the therapy of psoriasis | Current drug targets. Inflammation & allergy | 2004 | 545 | 0 | |||
| Prospective randomised comparison of traditional, personal bedside and problem-oriented practical dermatology courses | Medical education | 2004 | 562 | 0 | |||
| Druckdolente livide Papeln | Journal der Deutschen Dermatologischen Gesellschaft | 2004 | 536 | 0 | |||
| Praaurikulare Tumore bei einem Kleinkind. Differenzialdiagnose neuroektodermaler Syndrome | Der Hautarzt | 2004 | 562 | 0 | |||
| Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis | Journal of the American Academy of Dermatology | 2004 | 588 | 0 | |||
| Intolerance of fondaparinux in a patient allergic to heparins | Contact dermatitis | 2004 | 468 | 0 | |||
| Kind mit Atopie | MMW, Fortschritte der Medizin | 2004 | 476 | 0 | |||
| Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis | Cancer research | 2004 | 569 | 0 | |||
| Progrediente Alopezie mit Juckreiz | Journal der Deutschen Dermatologischen Gesellschaft | 2004 | 515 | 0 | |||
| Fehlender Bartwuchs bei einem 34jahrigen Patienten. Hypogonadotroper Hypogonadismus | Journal der Deutschen Dermatologischen Gesellschaft | 2004 | 527 | 0 | |||
| Der selektive Cyclooxygenase-2-Inhibitor Celecoxib ist ein sicheres Ausweichpraparat bei Intoleranz gegenuber nichtsteroidalen Antiphlogistika | Medizinische Klinik | 2003 | 528 | 0 | |||
| Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans | Contact dermatitis | 2003 | 469 | 0 | |||
| Proteasome inhibition: a new anti-inflammatory strategy | Journal of molecular medicine | 2003 | 642 | 0 | |||
| The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria | British journal of dermatology | 2003 | 544 | 0 | |||
| Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders? | Trends in pharmacological sciences | 2003 | 430 | 0 | |||
| The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders | Journal of investigative dermatology | 2003 | 556 | 0 | |||
| Immunomodulatory drugs for psoriasis | BMJ. British medical journal | 2003 | 590 | 294 | |||
| Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study | Contact dermatitis | 2003 | 606 | 0 | |||
| Effects of rofecoxib, celecoxib, and parecoxib on anti-IgE-induced histamine release from human skin mast cells and basophils | Allergy | 2003 | 565 | 0 | |||
| Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model | The Journal of clinical investigation | 2002 | 609 | 0 | |||
| Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation | Contact dermatitis | 2002 | 520 | 0 | |||
| Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease | Transplantation | 2002 | 591 | 0 | |||
| Urticaria associated with a small cell carcinoma of the lung | Cutis | 2002 | 482 | 0 | |||
| Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases | EJD. European journal of dermatology | 2002 | 537 | 0 | |||
| Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation | Nature medicine | 2002 | 552 | 0 | |||
| Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing | Contact dermatitis | 2002 | 468 | 0 | |||
| Allergic contact dermatitis from black cumin (Nigella sativa) oil-containing ointment | Contact dermatitis | 2002 | 561 | 0 | |||
| Tolerance to a group C corticosteroid systemically in a patient with delayed-type hypersensitivity to group A systemic corticosteroids | Contact dermatitis | 2002 | 569 | 0 | |||
| Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gamma | Journal of investigative dermatology | 2002 | 574 | 0 | |||
| Monitoring of phagocytic activity in histiocytic cytophagic panniculitis | Journal of the American Academy of Dermatology | 2001 | 584 | 0 | |||
| Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice | Journal of pathology | 2001 | 545 | 0 | |||
| Vertraglichkeit des selektiven Cyclooxygenase-2-Inhibitors Rofecoxib bei Intoleranz gegenuber nicht-steroidalen Antiphlogistika | Deutsche Medizinische Wochenschrift | 2001 | 574 | 0 | |||
| Mycophenolate mofetil is effective in the treatment of atopic dermatitis | Archives of dermatology | 2001 | 524 | 0 | |||
| The Western blot is a highly sensitive and efficient technique in diagnosing allergy to wasp venom | Clinical and experimental allergy | 2001 | 543 | 0 | |||
| Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3,396 patients | Dermatology | 2001 | 551 | 0 | |||
| Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model | Journal of investigative dermatology | 2001 | 595 | 0 | |||
| Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasis | The Journal of investigative dermatology symposium proceedings | 2001 | 565 | 0 | |||
| Heavy naphthen oil exhibits antipsoriatic efficacy in vivo and antiproliferative as well as differentiation-inducing effects on keratinocytes in vitro | Archives of dermatology | 2000 | 628 | 0 | |||
| Anaphylaxis to red currants | Allergy | 2000 | 540 | 0 | |||
| Delayed-type hypersensitivity reaction to kava-kava extract | Contact dermatitis | 2000 | 578 | 0 | |||
| Systemic photodynamic therapy is a safe and effective treatment for psoriasis | Archives of dermatology | 2000 | 537 | 0 | |||
| Is psoriasis a T-cell disease? | Experimental dermatology | 2000 | 546 | 0 | |||
| Expression of the basal cell adhesion molecule (B-CAM) in normal and diseased human skin | Journal of cutaneous pathology | 2000 | 567 | 0 | |||
| Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil | Journal of the American Academy of Dermatology | 2000 | 495 | 0 | |||
| Benzoyl peroxide as a contact allergen in adhesive tape | Contact dermatitis | 1999 | 635 | 0 | |||
| Allergic contact dermatitis from benzyl alcohol during topical antimycotic treatment | Contact dermatitis | 1999 | 583 | 0 | |||
| Ablative techniques in Psoriasis vulgaris resistant to conventional therapies | Dermatologic surgery | 1999 | 596 | 0 | |||
| Die Rolle bakterieller Superantigene in der Pathophysiologie der Haut | Der Hautarzt | 1999 | 519 | 0 | |||
| The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugs | Archives of dermatological research | 1999 | 495 | 0 | |||
| Selection of conserved TCR VDJ rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris | European Journal of Immunology | 1999 | 595 | 0 | |||
| The SCID-hu xenogeneic transplantation model: complex but telling | Archives of dermatological research | 1999 | 589 | 0 | |||
| Occupational protein contact dermatitis caused by meat and fish | International journal of dermatology | 1998 | 523 | 0 | |||
| The T-cell receptor Vbeta repertoire of nickel-specific T cells | Archives of dermatological research | 1998 | 500 | 0 | |||
| Identification of HLA-DR and -DQ alleles conferring susceptibility to pollen allergy and pollen associated food allergy | Clinical and experimental allergy | 1998 | 617 | 0 | |||
| Delayed-type reactivity to calcipotriol without cross-sensitization to tacalcitol | Contact dermatitis | 1997 | 543 | 0 | |||
| Graft persistence in animal models of psoriasis | Nature medicine | 1997 | 505 | 0 | |||
| Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis | British journal of dermatology | 1997 | 478 | 0 | |||
| Leg ulcers in Klinefelter's syndrome--further evidence for an involvement of plasminogen activator inhibitor-1 | British journal of dermatology | 1997 | 567 | 0 | |||
| Allergic contact dermatitis from diphenylthiourea in a wet suit | Contact dermatitis | 1997 | 492 | 0 | |||
| Alopecia areata but not androgenetic alopecia is characterized by a restricted and oligoclonal T-cell receptor-repertoire among infiltrating lymphocytes | Journal of cutaneous pathology | 1997 | 630 | 0 | |||
| Superantigens but not mitogens are capable of inducing upregulation of E-selectin ligands on human T lymphocytes | Experimental dermatology | 1997 | 570 | 0 | |||
| Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model | Journal of cutaneous pathology | 1997 | 575 | 0 | |||
| Psoriasis im Tiermodell | Der Hautarzt | 1997 | 514 | 1 | |||
| Nagellack-Allergie. Eine wichtige Differentialdiagnose bei Kontaktdermatitis | Deutsche Medizinische Wochenschrift | 1997 | 739 | 0 | |||
| Die photodynamische Therapie an der Schwelle zur klinischen Anwendung bei disseminierten Dermatosen | Der Hautarzt | 1996 | 473 | 0 | |||
| Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally | Contact dermatitis | 1996 | 510 | 0 | |||
| Intolerance to sodium metabisulfite in beer | Allergy | 1996 | 541 | 0 | |||
| Mensch-zu-Maus Xenotransplantationsmodelle komplementieren Transgene und knock-out Mause. Stellungnahme zur Arbeit von K. Sellheyer: Transgene Mause als Modelle fur Hautkrankheiten | Der Hautarzt | 1996 | 521 | 0 | |||
| Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids | Contact dermatitis | 1996 | 533 | 0 | |||
| Clinical and pathophysiological aspects of hydroxyethyl starch-induced pruritus: evaluation of 96 cases | Dermatology | 1996 | 578 | 0 | |||
| Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study | Journal of investigative dermatology | 1996 | 513 | 0 | |||
| Psoriasis and bacterial superantigens--formal or causal correlation? | Trends in microbiology | 1996 | 490 | 0 | |||
| Pulling the trigger on psoriasis | Nature | 1996 | 575 | 0 | |||
| Ethanol metabolite acetic acid as causative agent for type-1 hypersensitivity-like reactions to alcoholic beverages | Clinical and experimental allergy | 1996 | 592 | 0 | |||
| Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro | Lasers in surgery and medicine | 1996 | 568 | 0 | |||
| T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin | Journal of cutaneous pathology | 1996 | 606 | 0 | |||
| The superantigen exfoliative toxin induces cutaneous lymphocyte-associated antigen expression in peripheral human T lymphocytes | Immunology letters | 1996 | 637 | 0 | |||
| Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy | Acta dermato-venereologica | 1995 | 407 | 0 | |||
| T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated V beta regions | Journal of investigative dermatology | 1995 | 554 | 0 | |||
| A subset of macrophages located along the basement membrane ("lining cells") is a characteristic histopathological feature of psoriasis | The American journal of dermatopathology | 1995 | 530 | 0 | |||
| Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo | Archives of dermatological research | 1994 | 570 | 0 | |||
| Treatment of psoriasis by topical photodynamic therapy with polychromatic light | Lancet | 1994 | 493 | 0 | |||
| Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice | Archives of dermatological research | 1994 | 596 | 0 | |||
| Predominant usage of distinct T-cell receptor V beta regions by epidermotropic T cells in psoriasis | Experimental dermatology | 1994 | 571 | 0 | |||
| In vitro and in vivo effects of photodynamic therapy in cutaneous T cell lymphoma | Acta dermato-venereologica | 1994 | 549 | 0 | |||
| Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis | Human immunology | 1994 | 589 | 0 | |||
| Differential expression of heat shock protein 70 (HSP70) and heat shock cognate protein 70 (HSC70) in human epidermis | Archives of dermatological research | 1994 | 525 | 0 | |||
| Primary subcutaneous leiomyosarcoma exhibiting the characteristic immunophenotype positive for vimentin and desmin | The Journal of dermatologic surgery and oncology | 1994 | 591 | 0 | |||
| Evidence for a pathway independent from 2'-deoxyguanosine and reversible by IL-2 by which purine nucleoside phosphorylase inhibitors block T-cell proliferation | Scandinavian journal of immunology | 1994 | 561 | 0 | |||
| Clonal disease in early cutaneous T-cell lymphoma | Dermatologic clinics | 1994 | 499 | 0 | |||
| Discrimination between immunoaccessory and phagocytic monocytes/macrophages of the skin in paraffin-embedded tissue by the monoclonal antibody Ki-M1P | British journal of dermatology | 1993 | 511 | 0 | |||
| Osteoma cutis. Multiple miliare Osteome des Gesichts | Der Hautarzt | 1993 | 525 | 0 | |||
| Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, -DQA1*0201, -DQB1*0303 extended haplotype | Journal of investigative dermatology | 1993 | 559 | 0 | |||
| The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition | The Journal of immunology | 1993 | 583 | 0 | |||
| A majority of proliferating T cells in cutaneous malignant T cell lymphomas may lack the high affinity IL-2 receptor (CD25) | Archives of dermatological research | 1993 | 573 | 0 | |||
| Role of beta 1-integrins in epidermotropism of malignant T cells | The American journal of pathology | 1992 | 546 | 0 | |||
| Demonstration of clonal disease in early mycosis fungoides | The American journal of dermatopathology | 1992 | 548 | 0 | |||
| Differential expression of adhesion molecules on infiltrating cells in inflammatory dermatoses | Journal of the American Academy of Dermatology | 1992 | 493 | 0 | |||
| Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules | Nature | 1991 | 497 | 0 | |||
| Type I and type II psoriasis show a similar usage of T-cell receptor variable regions | Journal of investigative dermatology | 1991 | 573 | 0 | |||
| Plasma cells in the dermal infiltrate of mycosis fungoides are of polyclonal origin | Acta dermato-venereologica | 1989 | 542 | 0 | |||
| C-type particles are inducible in Se-Ax, a continuous T-cell line from a patient with Sezary's syndrome | Archives of dermatological research | 1988 | 534 | 0 |
